1800 244 735

Helpline (02) 9874 9777

HD Service at Westmead approved to participate in 2 new drug trials

 

The Huntington Disease Service at Westmead Hospital has been approved to participate in two new drug trials, called PRECISION-HD1 and PRECISION-HD2. Each study tests a separate Huntingtin-lowering (also known as gene silencing) agent. They are run by a company called Wave Life Sciences based in Massachusetts, USA. The studies involve lumbar punctures, MRI scans, assessments and questionnaires.

These are Phase 1b/2a trials, meaning that they are testing an experimental treatment in humans for the first time. The main goal is to assess whether the treatments are safe and well tolerated in the treatment of Huntington’s disease when compared with a placebo control. Participants must be between the ages of 25-65, have early stage Huntington’s disease, and meet additional criteria.

The study has already commenced overseas. Information can be found at https://clinicaltrials.gov/ct2/show/NCT03225833?recrs=a&cond=huntington%27s+disease&draw=2&rank=16 and https://clinicaltrials.gov/ct2/show/NCT03225846?recrs=a&cond=huntington%27s+disease&draw=2&rank=15. It is expected that together the two studies will involve approximately 96 people worldwide.

If you would like more information, you can call the Huntington Disease Service at Westmead on 0456 740 612. The phone will be monitored on Mondays and Thursdays. Please leave a message if we do not answer when you call.

Huntington’s NSW & ACT and the Huntington Disease Service at Westmead will continue to provide updates on HD research through the Huntington’s NSW & ACT website and Facebook page

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest News and Stories

Neurological Alliance Australia Position Statement on Aged Care – Dec 2020

Published date: 13 January, 2021

Huntington’s NSW ACT is a member of the Neurological Alliance Australia on behalf of all State Associations. This Position Statement on Aged Care comes with an important reminder that over half of those with HD living in residential care are in aged care homes.

The Year That Was….

Published date: 8 December, 2020

As we approach the end of the year and the Christmas holidays we are all a little unsure whether we will be getting together with family members and loved ones to share the festive season in the way we always do. One thing we can be sure of is that we will look back on ... Read more
Person taking notes at a meeting

Community Survey 2020

Published date: 6 December, 2020

Participate by 31/12/20 for your chance to WIN a free weekends accomodation near Wollombi.
International Day of People with Disability logo

International Day of People with Disability

Published date: 2 December, 2020

We are committed to empowering people with HD to live their best possible life. We want to see all people impacted by HD treated with equity by governments, other institutions and their communities. #idpwd #disablestereotypes #advocacymatters #abilitynotdisability #huntingtonsdisease

Prof Elizabeth McCusker interview

Published date: 25 November, 2020

Special guest speaker at our 2020 annual general meeting to recognise her retirement after many years as both a clinical and research leader.

Hunt4Hope Op Shop

Published date: 17 November, 2020

The Hunt4Hope Shop is a self-funded business where Matina, the owner, chooses to give 100% of the profits to Huntington’s NSW ACT who helps those affected by Huntington’s Disease.